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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to 
vitamin D and contribution to normal bone and tooth development 
pursuant to Article 14 of Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Specialised Nutrition Europe (formerly IDACE), submitted pursuant to Article 14 
of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, 
Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim 
related to vitamin D and contribution to normal development of bones and teeth. The food constituent, vitamin 
D, which is the subject of the health claim, is sufficiently characterised. Contribution to normal development of 
bones and teeth is a beneficial physiological effect for infants and young children. A claim on vitamin D and 
maintenance of normal bones and teeth in the general population has already been assessed with a favourable 
outcome. The Panel considers that the role of vitamin D in bone and tooth mineralisation and homeostasis 
applies to all ages, including infants and young children (from birth to three years). The Panel concludes that a 
cause and effect relationship has been established between the dietary intake of vitamin D and contribution to 
normal development of bones and teeth. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for 
authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the 
Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 
was asked to deliver an opinion on the scientific substantiation of a health claim related to vitamin D 
and contribution to normal development of bones and teeth. 
The scope of the application was proposed to fall under a health claim referring to children’s 
development and health. 
The food constituent that is the subject of the health claim is vitamin D, which is an essential nutrient 
and is measurable in foods by established methods. The Panel considers that vitamin D is sufficiently 
characterised. 
The claimed effect proposed by the applicant is “vitamin D is essential for the absorption and 
utilization of calcium and phosphorus in building strong teeth and bones”. The target population 
proposed by the applicant is infants and young children from birth to three years of age. The Panel 
considers that contribution to normal development of bones and teeth is a beneficial physiological 
effect for infants and young children. 
A claim on vitamin D and maintenance of normal bones and teeth in the general population has 
already been assessed with a favourable outcome. The conclusion of the Panel was based on the well 
established role of vitamin D in bone and tooth metabolism as shown by the evidence provided by 
consensus opinions/reports from authoritative bodies and reviews. 
The Panel considers that the role of vitamin D on bone and tooth mineralisation and homeostasis 
applies to all ages, including infants and young children (from birth to three years). 
The Panel concludes that a cause and effect relationship has been established between the dietary 
intake of vitamin D and contribution to normal development of bones and teeth. 
The following wording reflects the scientific evidence: “Vitamin D contributes to normal development 
of bones and teeth”. 
The Panel considers that in order to bear the claim, follow-on formulae should comply with the criteria 
of composition of follow-on formulae as laid down in Directive 2006/141/EC; nutritionally complete 
foods for special medical purposes intended for use by infants and nutritionally complete foods for 
special medical purposes other than those intended for use by infants should comply with the criteria 
of composition of these foods as laid down in Directive 1999/21/EC; processed cereal-based foods for 
infants and young children should comply with the criteria of composition of these foods as laid down 
in Directive 2006/125/EC; other foodstuffs intended for infants and young children should provide at 
least 15 % of the reference values for nutrition labelling for foods intended for infants and young 
children as laid down in Directive 2006/141/EC. Such amounts can be easily consumed as part of a 
balanced diet. The target population is infants and children up to three years. A Tolerable Upper Intake 
Level has been established for vitamin D in this age group. 
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BACKGROUND 
Regulation (EC) No 1924/2006
4
 harmonises the provisions that relate to nutrition and health claims, 
and establishes rules governing the Community authorisation of health claims made on foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of 
this Regulation, are authorised in accordance with this Regulation, and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular, Articles 14 to 17 of this 
Regulation lay down provisions for the authorisation and subsequent inclusion of reduction of disease 
risk claims and claims referring to children’s development and health in a Community list of 
permitted claims. 
According to Article 15 of this Regulation, an application for authorisation shall be submitted by the 
applicant to the national competent authority of a Member State, which will make the application and 
any supplementary information supplied by the applicant available to the European Food Safety 
Authority (EFSA). 
STEPS TAKEN BY EFSA 
 The application was received on 14/02/2008. 
 The scope of the application was proposed to fall under a health claim referring to children’s 
development and health. 
 On 26/03/2008, during the validation process of the application, EFSA sent a request to the 
applicant to provide missing information. 
 On 22/07/2013, EFSA received the missing information as submitted by the applicant. 
 The scientific evaluation procedure started on 03/12/2013. 
 During its meeting on 05/02/2014, the NDA Panel, having evaluated the data submitted, 
adopted an opinion on the scientific substantiation of a health claim related to vitamin D and 
contribution to normal bone and tooth development. 
TERMS OF REFERENCE 
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with 
Article 16 of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: vitamin D and contribution to 
normal development of bones and teeth. 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation for the 
marketing of vitamin D, a positive assessment of its safety, or a decision on whether vitamin D is, or 
is not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the 
framework of Regulation (EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 17 of Regulation (EC) No 1924/2006. 
                                                     
4 Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. 
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address: Specialised Nutrition Europe (formerly IDACE), 9-31 Avenue des 
Nerviens, 1040 Brussels, Belgium. 
Food/constituent as stated by the applicant 
According to the applicant, the food constituent for which the claim is made is vitamin D. 
Health relationship as claimed by the applicant 
According to the applicant, vitamin D is essential for the absorption and utilization of calcium and 
phosphorus in building strong teeth and bones. 
Wording of the health claim as proposed by the applicant 
The applicant has proposed the following wording for the health claim: “vitamin D is essential for the 
absorption and utilization of calcium and phosphorus in building strong teeth and bones”. 
As equivalent alternative wordings, the applicant has also proposed: “vitamin D is essential for the 
structure of bones/healthy bones”; “vitamin D helps to build and maintain strong/healthy bones”; 
“vitamin D is necessary for adequate bone density”; “vitamin D helps build strong bones”; “vitamin 
D is needed for the development of healthy bones”; “vitamin D is necessary for the absorption 
and  utilisation of calcium and phosphorus”; “vitamin D is essential for the absorption and 
utilization of calcium and phosphorus in building strong bones”; “vitamin D promotes the absorption 
of calcium for healthy bones”; “vitamin D is necessary for calcium uptake in bones”. 
Specific conditions of use as proposed by the applicant 
According to the applicant, the target population is infants and young children from birth to three 
years of age. 
According to the applicant, the quantity needed to achieve the claimed effect is: 
 For follow-on formulae, the content in vitamin D should be within the range set in Directive 
2006/141/EC. 
 For dietary foods for special medical purposes, the content in vitamin D should be within the 
range set in Directive 1999/21/EC. 
 For processed cereal-based foods and baby foods, the content in vitamin D should be within 
the range set in Directive 2006/125/EC. 
 For processed cereal-based foods and baby foods, the content in vitamin D should reach at 
least 15 % of the Nutrient Reference Values set in Directive 2006/125/EC, i.e. 15 % of 10 μg 
per 100 g or 100 ml or per serving, as reconstituted. 
 For foods intended for infants and young children other than follow-on formulae, processed 
cereal-based foods and baby foods, the content in vitamin D should reach at least 15 % of the 
Nutrient Reference Values set in Directive 2006/141/EC, i.e. 15 % of 7 µg per 100 ml product 
ready for use. 
Vitamin D and normal bone and tooth development 
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ASSESSMENT 
1. Characterisation of the constituent 
The food constituent that is the subject of the health claim is vitamin D, which is an essential nutrient 
and is measurable in foods by established methods. 
Vitamin D occurs naturally in foods as vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). 
Different forms of vitamin D are authorised for addition to foods and for use in food supplements 
(Annex II of Regulation (EC) No 1925/2006
5
, Annex II of Directive 2002/46/EC
6
, Annex III of 
Directive 2006/141/EC
7
, Annex IV of Directive 2006/125/EC
8
, Directive 2001/15/EC
9
). This 
evaluation applies to vitamin D naturally present in foods and those forms authorised for addition to 
foods (Annex II of Regulation (EC) No 1925/2006, Annex II of Directive 2002/46/EC, Annex III of 
Directive 2006/141/EC, Annex IV of Directive 2006/125/EC, Directive 2001/15/EC). 
The Panel considers that the food constituent, vitamin D, which is the subject of the health claim, is 
sufficiently characterised. 
2. Relevance of the claimed effect to human health 
The claimed effect proposed by the applicant is “vitamin D is essential for the absorption and 
utilization of calcium and phosphorus in building strong teeth and bones” and refers to the importance 
of vitamin D for a normal bone and tooth development. The target population proposed by the 
applicant is infants and young children from birth to three years of age. 
The Panel considers that contribution to normal development of bones and teeth is a beneficial 
physiological effect for infants and young children. 
3. Scientific substantiation of the claimed effect 
The applicant performed a literature search in PubMed and Google Scholar, using the search terms: 
“vitamin D”, “bone mineral density”, “bone mineral content” and “bone mass accretion” and with 
the following limits: “humans”, “randomized controlled trial”, published in English with no time 
limitations, for age “birth – 23 months” and “2-5 years”. 
The applicant identified seven human intervention studies (Greer et al., 1981; Chan et al., 1982; Greer 
et al., 1982; Greer et al., 1989; Koo et al., 1995; Backström et al., 1999a; Backström et al., 1999b), 11 
authoritative bodies opinions/recommendations (FoSIM, 1985; CEDAP, 1997; CFIA, 2003; JHCI, 
2003; FNFC/FOSHU, 2001; NHPD, 2004; SNF, 2004; OFSP, 2006; EFSA 2008a, EFSA 2008b; 
EFSA 2008c), 13 reviews (Southard et al., 1991; Tomassi et al., 1996; Cioffia et al., 1997; Namgung 
and Tsang, 2000; Liu et al., 2001; Mølgard and Michaelsen, 2003; Ruff, 2003; Cranney et al., 2007; 
Rigo et al., 2007; Cranney et al., 2008; Greer et al., 2008; Holick et al., 2008; Holick et al., 2009), and 
seven “other” references (Emmett et al., 1996; Brunwald and Brunvatne, 2001; Noble et al., 2001; Pal 
and Shaw, 2001; Sichert-Hellert et al., 2006; Huybrechts and De Henauw, 2007; Fantino et al., 2008) 
as relevant for the claim. 
                                                     
5 Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404, 30.12.2006, p. 26–38. 
6 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183, 12.7.2002, p. 51–57. 
7 Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending 
Directive 1999/21/EC Text with EEA relevance. OJ L 401, 30.12.2006, p. 1–33. 
8 Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and 
young children. OJ L 339, 6.12.2006, p. 16–35. 
9 Commission Directive 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes 
in foods for particular nutritional uses. OJ L 52, 22.2.2001, p. 19–25. 
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The evidence provided by consensus opinions/reports from authoritative bodies and reviews shows 
that there is a consensus on the role of vitamin D in growth, development and maintenance of bones 
and teeth. It is well established that an adequate status for vitamin D is required for efficient calcium 
absorption and for the maintenance of normal blood concentrations of calcium and phosphate that are 
in turn needed for the normal mineralisation of bones and teeth. An adequate intake of vitamin D is 
needed to achieve a vitamin D status that is sufficient for normal bone and tooth mineralisation 
throughout childhood and adolescence and for bone maintenance in adults and the elderly. Low 
vitamin D status has been shown to reduce bone mineral accretion in children and adolescents, and to 
accelerate bone loss in adults and older people. Recommended intakes of vitamin D to meet 
requirements for growth, development and maintenance of bones and teeth have been established for 
all life-stage groups by several expert committees. Low vitamin D status has been reported in 
subgroups of children, adolescents, adults and the elderly in a number of European countries, 
particularly in winter months, indicative of inadequate vitamin D intake (SCF, 1993; IoM, 1997; 
AFSSA, 2001; FAO/WHO 2001; EVM, 2002; SCF 2002; Ovesen et al., 2003; Holick, 2004; Davies 
et al., 2005; Holick, 2005; Greer et al., 2006; Cranney et al., 2007; Norman et al., 2007). 
The Panel has already assessed a claim on vitamin D and maintenance of normal bones and teeth with 
a favourable outcome (EFSA NDA Panel, 2009). The target population was the general population. 
The conclusion of the Panel was based on the well established role of vitamin D in bone and tooth 
metabolism as shown by the evidence provided by consensus opinions/reports from authoritative 
bodies and reviews. 
The Panel considers that the role of vitamin D on bone and tooth mineralisation and homeostasis 
applies to all ages, including infants and young children (from birth to three years). 
The Panel concludes that a cause and effect relationship has been established between the dietary 
intake of vitamin D and contribution to normal development of bones and teeth. 
4. Panel’s comments on the proposed wording 
The Panel considers that the following wording reflects the scientific evidence: “Vitamin D 
contributes to normal development of bones and teeth”. 
5. Conditions and restrictions of use 
The Panel considers that in order to bear the claim: 
 follow-on formulae should comply with the criteria of composition of follow-on formulae as 
laid down in Directive 2006/141/EC; 
 nutritionally complete foods for special medical purposes intended for use by infants and 
nutritionally complete foods for special medical purposes other than those intended for use by 
infants should comply with the criteria of composition of these foods as laid down in 
Directive 1999/21/EC
10
; 
 processed cereal-based foods for infants and young children should comply with the criteria 
of composition of these foods as laid down in Directive 2006/125/EC; 
 other foodstuffs intended for infants and young children should provide at least 15 % of the 
reference values for nutrition labelling for foods intended for infants and young children as 
laid down in Directive 2006/141/EC. 
                                                     
10 Commission Directive 1999/21/EC of 25 March 1999 on dietary foods for special medical purposes. OJ L 91, 7.4.1999, 
p. 29–36. 
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Such amounts can be easily consumed as part of a balanced diet. The target population is infants and 
children up to three years. A Tolerable Upper Intake Level (UL) has been established for vitamin D in 
this age group, and has been set at 25 μg/day for infants and 50 µg/day for children aged 1 – 10 years 
(EFSA NDA Panel, 2012). 
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
 The food constituent, vitamin D, which is the subject of the health claim, is sufficiently 
characterised. 
 The claimed effect proposed by the applicant refers to the importance of vitamin D for  
normal bone and tooth development. The target population proposed by the applicant is 
infants and young children from birth to three years of age. Contribution to normal bone and 
tooth development is a beneficial physiological effect for infants and young children. 
 A cause and effect relationship has been established between the dietary intake of vitamin D 
and contribution to normal development of bones and teeth. 
 The following wording reflects the scientific evidence: “vitamin D contributes to normal 
development of bones and teeth”. 
 In order to bear the claim, follow-on formulae should comply with the criteria of composition 
of follow-on formulae as laid down in Directive 2006/141/EC; nutritionally complete foods 
for special medical purposes intended for use by infants and nutritionally complete foods for 
special medical purposes other than those intended for use by infants should comply with the 
criteria of composition of these foods as laid down in Directive 1999/21/EC; processed 
cereal-based foods for infants and young children should comply with the criteria of 
composition of these foods as laid down in Directive 2006/125/EC; other foodstuffs intended 
for infants and young children should provide at least 15 % of the reference values for 
nutrition labelling for foods intended for infants and young children as laid down in 
Directive 2006/141/EC. Such amounts can be easily consumed as part of a balanced diet. The 
target population is infants and children up to three years. A Tolerable Upper Intake Level has 
been set at 25 μg/day for infants and 50 µg/day for children aged 1 – 10 years. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on vitamin D and normal development of bones and teeth pursuant to 
Article 14 of Regulation (EC) No 1924/2006 (Claim serial No: 0098_FR). February 2008. Submitted 
by Specialised Nutrition Europe (formerly IDACE). 
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